<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> news | </title> <meta name="author" content="Melissa Barber"> <meta name="description" content="Economist researching pharmaceutical markets."> <meta name="keywords" content="jekyll, jekyll-theme, academic-website, portfolio-website"> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" href="/assets/css/scholar-icons.css?62b2ac103a88034e6882a5be5f3e2772"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="/assets/img/pill_favicon.png?b43d092d03e013925c15ff3061e766cf"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://melissajbarber.github.io/news/"> <script src="/assets/js/theme.js?a81d82887dd692e91686b43de4542f18"></script> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script>
    initTheme();
  </script> </head> <body class="fixed-top-nav sticky-bottom-footer"> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"> </a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item dropdown "> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">policy </a> <div class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdown"> <a class="dropdown-item " href="/congressional_testimony/">Congressional testimony</a> <a class="dropdown-item " href="/reports/">reports</a> <a class="dropdown-item " href="/public_comments/">public comments</a> </div> </li> <li class="nav-item "> <a class="nav-link" href="/talks/">talks </a> </li> <li class="nav-item "> <a class="nav-link" href="/teaching/">teaching </a> </li> <li class="nav-item active"> <a class="nav-link" href="/news/">news <span class="sr-only">(current)</span> </a> </li> <li class="nav-item "> <a class="nav-link" href="/people/">people </a> </li> <li class="nav-item"> <button id="search-toggle" title="Search" onclick="openSearchModal()"> <span class="nav-link">ctrl k <i class="ti ti-search"></i></span> </button> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="ti ti-sun-moon" id="light-toggle-system"></i> <i class="ti ti-moon-filled" id="light-toggle-dark"></i> <i class="ti ti-sun-filled" id="light-toggle-light"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title">news</h1> <p class="post-description"></p> </header> <article> <h4 id="television-radio-and-podcasts">television, radio, and podcasts</h4> <p>Feb 2025: <a href="https://www.wbur.org/onpoint/2025/02/28/wegovy-ozempic-shortage-fda-compounding-pharmacy" rel="external nofollow noopener" target="_blank">Weight loss drugs may become harder to get. What does that mean for patients?</a>. WBUR [NPR station].</p> <p>Sept 2024: <a href="https://www.bbc.co.uk/sounds/play/w172zb92nd09p3s" rel="external nofollow noopener" target="_blank">Recap of Novo Nordisk Hearing</a>. BBC World Service.</p> <p>Sept 2024: <a href="https://www.youtube.com/watch?v=JqHmvMjXuro" rel="external nofollow noopener" target="_blank">What the Maker of Ozempic Doesn’t Want You to Know: It’s Bankrupting America</a>. More Perfect Union.</p> <iframe width="560" height="315" src="https://www.youtube.com/embed/JqHmvMjXuro?start=275" frameborder="0" allowfullscreen=""></iframe> <p>June 2024: <a href="https://edition.cnn.com/2024/06/18/politics/video/the-lead-bernie-sanders-wegovy-ozempic-prices-helthcare-isarel-gaza-war-jake-tapper" rel="external nofollow noopener" target="_blank">Sanders calls on Ozempic maker to lower price of drug</a>. CNN interview with Senator Bernie Sanders.</p> <p>Apr 2024: <a href="https://www.nbcnews.com/health/health-news/one-state-trying-make-weight-loss-drugs-cheaper-rcna148997" rel="external nofollow noopener" target="_blank">How one state is trying to make weight loss drugs cheaper</a>. NBC.</p> <p>Apr 2024: <a href="https://www.msnbc.com/ana-cabrera-reports/watch/bernie-sanders-american-people-are-sick-and-tired-of-being-ripped-off-by-drug-companies-208144965580" rel="external nofollow noopener" target="_blank">American people are ‘sick and tired’ of being ‘ripped off by drug companies’</a>. MSNBC interview with Senator Bernie Sanders.</p> <p>Mar 2024: <a href="https://www.youtube.com/watch?v=AQXwtb2_da8" rel="external nofollow noopener" target="_blank">New study details costs of making diabetes drugs</a>. CNBC “Fast Money”.</p> <iframe width="560" height="315" src="https://www.youtube.com/embed/AQXwtb2_da8" frameborder="0" allowfullscreen=""></iframe> <p>Sept 2023: <a href="https://www.c-span.org/video/?530442-1/house-hearing-generic-drug-supply" rel="external nofollow noopener" target="_blank">Hearing: Legislative Proposals to Prevent and Respond to Generic Drug Shortages</a>. C-SPAN.</p> <p>Sept 2022: <a href="https://armandalegshow.com/episode/california-making-insulin/" rel="external nofollow noopener" target="_blank">California plans to make its own insulin and sell it super-cheap. Really.</a> An Arm and a Leg.</p> <p>Jan 2022: <a href="https://www.raiplay.it/video/2022/01/La-vigile-attesa---Report-31012022-667606d9-ff1e-4323-9add-0669ab47e532.html?wt_mc=2.www.wzp.raiplay_dati" rel="external nofollow noopener" target="_blank">Report: La vigile attesa</a>. RAI (Radiotelevisione italiana).</p> <p>Oct 2021: <a href="https://radiocut.fm/audiocut/molnupiravir-cost-based-estimated-generic-prices" rel="external nofollow noopener" target="_blank">KNX In Depth (live LA current affairs radio show)</a>. KNX Radio</p> <hr> <h4 id="print-and-online-media">print and online media</h4> <div style="text-align: center;"> <h5>2025</h5> </div> <p>Apr 17: <a href="https://timesofindia.indiatimes.com/india/patients-of-rare-disease-welcome-prospect-of-dramatic-slash-in-price-of-drug/articleshow/120382558.cms" rel="external nofollow noopener" target="_blank">Patients of rare disease welcome prospect of dramatic slash in price of drug</a>. The Times of India.</p> <p>Apr 16: <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/pharma-companies-expected-absorb-any-tariff-hit-short-term-2025-04-16/" rel="external nofollow noopener" target="_blank">Pharma companies expected to absorb any tariff hit in short term</a>. Reuters.</p> <p>Mar 26: <a href="https://indianexpress.com/article/cities/delhi/delhi-hc-sma-drug-risdiplam-natco-swiss-pharma-roche-9905857/" rel="external nofollow noopener" target="_blank">Indian company can now make Spinal Muscular Atrophy drug, High Court cites public interest</a>. Indian Express.</p> <p>Mar 24: <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-rejects-roches-plea-to-block-natco-pharma-on-risdiplam-patent/articleshow/119435137.cms" rel="external nofollow noopener" target="_blank">Delhi HC rejects Roche’s plea to block Natco Pharma on Risdiplam patent</a>. Economic Times.</p> <p>Mar 18: <a href="https://genevahealthfiles.substack.com/p/balancing-health-rights-and-resources-rare-diseases-india-resolution-access-to-medicines-cost-intellectual-property-supreme-court-kerala-seba" rel="external nofollow noopener" target="_blank">Balancing Health Rights and Resource Constraints: The Dilemma of Rare Disease Treatment in India</a>. Geneva Health Files.</p> <p>Mar 13: <a href="https://observervoice.com/trumps-tariffs-threaten-us-drug-prices-102880/" rel="external nofollow noopener" target="_blank">Trump’s Tariffs Threaten US Drug Prices</a>. Observer Voice.</p> <p>Mar 12: <a href="https://www.bbc.com/news/articles/ckg8ke45gq0o" rel="external nofollow noopener" target="_blank">US tariffs on India will be a bitter pill to swallow</a>. BBC.</p> <p>Feb 28: <a href="https://timesofindia.indiatimes.com/india/high-cost-patented-drugs-a-crippling-blow-to-those-with-rare-diseases/articleshow/118627756.cms" rel="external nofollow noopener" target="_blank">High cost patented drugs a crippling blow to those with rare diseases</a>. The Times of India.</p> <p>Feb 12: <a href="https://undark.org/2025/02/12/expanding-access-glp1/" rel="external nofollow noopener" target="_blank">For Many, Weight-Loss Drugs Are Pricey. Expanding Access Is Hard</a>. Undark Magazine.</p> <p>Feb 2: <a href="https://yaledailynews.com/blog/2025/02/02/yale-experts-weigh-in-on-u-s-who-exit/" rel="external nofollow noopener" target="_blank">Yale experts weigh in on U.S. WHO exit</a>. Yale News.</p> <p>Jan 25: <a href="https://www.thehindu.com/sci-tech/health/experts-seek-affordable-access-to-medicines-for-treating-spinal-muscular-atrophy/article69072252.ece" rel="external nofollow noopener" target="_blank">People with spinal muscular atrophy demand urgent action from the Centre to reduce medicine costs</a>. The Hindu.</p> <p>Jan 20: <a href="https://spicyip.com/2025/01/a-rare-invocation-for-a-rare-disease-government-urged-to-invoke-section-100-patents-act-for-rare-disease-medicine.html" rel="external nofollow noopener" target="_blank">A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine.</a> SpicyIP</p> <p>Jan 8: <a href="https://www.thehindu.com/sci-tech/health/experts-seek-affordable-access-to-medicines-for-treating-spinal-muscular-atrophy/article69072252.ece" rel="external nofollow noopener" target="_blank">Experts seek affordable access to medicines for treating Spinal Muscular Atrophy</a>. The Hindu.</p> <div style="text-align: center;"> <h5>2024</h5> </div> <p>Nov 10: <a href="https://timesofindia.indiatimes.com/home/sunday-times/all-that-matters/how-many-patients-must-die-to-pay-the-debt-to-drug-innovation-dr-melissa-barber/articleshow/115122367.cms" rel="external nofollow noopener" target="_blank">How many patients must die to pay the debt to drug innovation: Interview with Dr Melissa Barber</a>. Times of India. <a href="https://scholar.harvard.edu/sites/scholar.harvard.edu/files/melissabarber/files/print_times_of_india.jpg?m=1734699873" rel="external nofollow noopener" target="_blank">Print version</a></p> <p>Nov 6: <a href="https://www.hindustantimes.com/india-news/patient-health-body-opposes-move-to-bar-generic-sma-drug-101730833683271.html" rel="external nofollow noopener" target="_blank">Patient health body opposes move to bar generic SMA drug</a>. Hindustan Times.</p> <p>Nov 6: <a href="https://www.telegraphindia.com/india/swiss-firm-roche-bid-to-prevent-indias-natco-pharma-from-introducing-cheap-spinal-drug/cid/2060900" rel="external nofollow noopener" target="_blank">Swiss firm Roche bid to prevent India’s Natco Pharma from introducing cheap spinal drug</a>. The Telegraph.</p> <p>Nov 6: <a href="https://health.economictimes.indiatimes.com/news/industry/patents-and-high-price-barriers-patients-with-rare-diseases-face-woes-to-access-medicines-from-mncs/114998204" rel="external nofollow noopener" target="_blank">Patents and high price barriers: patients with rare diseases face woes to access medicines from MNCs</a>. The Economic Times.</p> <p>Nov 5: <a href="https://www.indiatoday.in/health/story/how-rare-genetic-disease-sma-drug-risdiplam-priced-at-rs-72-lakh-can-be-developed-in-rs-3000-2627702-2024-11-05" rel="external nofollow noopener" target="_blank">How a Rs 72 lakh drug for a rare genetic disease could cost just Rs 3,000</a>. India Today.</p> <p>Oct 28: <a href="https://timesofindia.indiatimes.com/india/rs-72-lakh/year-rare-disease-drug-can-be-made-for-rs-3000/year-hc-told/articleshow/114666406.cms" rel="external nofollow noopener" target="_blank">Rs 72 lakh/year rare-disease drug can be made for Rs 3,000/year, High Court told</a>. Times of India.</p> <p>Oct 28: (Could a Rs 72 lakh drug cost just Rs 3,000? A 24-year-old’s courtroom revelation.)[https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/could-a-rs-72-lakh-drug-cost-just-rs-3000-a-24-year-olds-courtroom-revelation/articleshow/114679955.cms]. Economic Times.</p> <p>Oct 7: <a href="https://www.nytimes.com/2024/10/02/health/lenacapavir-hiv-shot-prep.html" rel="external nofollow noopener" target="_blank">Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries</a>. New York Times.</p> <p>Sept 24: <a href="https://www.usatoday.com/story/news/health/2024/09/24/senate-hearing-novo-nordisk-ceo-ozempic-wegovy-prices/75348020007" rel="external nofollow noopener" target="_blank">Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers</a>. USA Today.</p> <p>Sept 24: <a href="https://www.washingtonpost.com/business/2024/09/24/ozempic-weight-loss-price-sanders" rel="external nofollow noopener" target="_blank">Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad</a>. Washington Post.</p> <p>Sept 23: <a href="https://rollcall.com/2024/09/23/analysts-say-market-forces-will-lower-cost-of-obesity-drugs" rel="external nofollow noopener" target="_blank">Analysts say market forces will lower cost of obesity drugs</a>. Roll Call.</p> <p>July 5: <a href="https://www.yalealumnimagazine.com/articles/5891-health-if-you-can-afford-it" rel="external nofollow noopener" target="_blank">Health—if you can afford it</a>. Yale Alumni Magazine.</p> <p>July 2: <a href="https://eu.usatoday.com/story/opinion/2024/07/02/biden-sanders-prescription-drug-cost-ozempic-wegovy/74232827007" rel="external nofollow noopener" target="_blank">President Biden: Novo Nordisk, Eli Lilly must stop ripping off Americans with high drug prices</a>. USA Today.</p> <p>June 26: <a href="https://www.forbes.com/sites/robertpearl/2024/06/24/weight-loss-drugmakers-are-overcharging-by-400-heres-a-quick-solution" rel="external nofollow noopener" target="_blank">Wegovy And Ozempic Are Overpriced By 400-500% — Here’s A Quick Solution</a>. Forbes.</p> <p>May 2: <a href="https://www.aljazeera.com/economy/2024/5/2/what-is-behind-the-insulin-shortage-in-the-us" rel="external nofollow noopener" target="_blank">What is behind the insulin shortage in the US?</a>. Al Jazeera.</p> <p>Apr 29: <a href="https://timesofindia.indiatimes.com/home/sunday-times/msf-publishes-clinical-trial-cost-challenges-pharma-to-do-the-same/articleshow/109671392.cms" rel="external nofollow noopener" target="_blank">MSF publishes clinical trial cost, challenges pharma to do the same</a>. The Times of India.</p> <p>Apr 25: <a href="https://www.theguardian.com/global-development/2024/apr/25/cost-of-developing-new-drugs-may-be-far-lower-than-industry-claims-trial-reveals" rel="external nofollow noopener" target="_blank">Cost of developing new drugs may be far lower than industry claims, trial reveals</a>. The Guardian.</p> <p>Apr 24: <a href="https://www.nytimes.com/2024/04/24/opinion/ozempic-wegovy-weight-glp1.html" rel="external nofollow noopener" target="_blank">This Is What a Miracle Drug Looks Like, and It Costs Only $5 to Make</a>. The New York Times.</p> <p>Apr 24: <a href="https://medicine.yale.edu/internal-medicine/news-article/diabetes-medication-lower-costs" rel="external nofollow noopener" target="_blank">Diabetes Medication Can Be Manufactured at Lower Cost, New Study Says</a>. Yale News.</p> <p>Apr 16: <a href="https://www.infosperber.ch/gesundheit/fett-weg-spritzen-koennten-statt-150-nur-20-franken-kosten" rel="external nofollow noopener" target="_blank">«Fett-weg»-Spritzen könnten statt 150 nur 20 Franken kosten</a>. Infosperber.</p> <p>Apr 6: <a href="https://elpais.com/planeta-futuro/2024-04-06/el-estilo-de-vida-europeo-que-asfixia-la-salud-publica-de-africa.html" rel="external nofollow noopener" target="_blank">El “estilo de vida europeo” que asfixia la salud pública de África</a>. El Pais.</p> <p>Apr 2: <a href="https://www.larazon.es/sociedad/msf-denuncia-desorbitados-precios-nuevos-medicamentos-diabetes_20240402660b83630999030001ca062a.html" rel="external nofollow noopener" target="_blank">MSF denuncia los “desorbitados” precios de los nuevos medicamentos para la diabetes</a>. La Razón (Spain).</p> <p>Apr 1: <a href="https://www.developmentaid.org/news-stream/post/177039/msf-global-double-diabetes-care" rel="external nofollow noopener" target="_blank">MSF study reveals global double standard in diabetes care</a>. Development Aid.</p> <p>Mar 29: <a href="https://www.telegraphindia.com/health/research-flags-excessive-profiteering-on-diabetes-drugs-by-sections-of-pharmaceutical-industry/cid/2009774" rel="external nofollow noopener" target="_blank">Research flags excessive ‘profiteering’ on diabetes drugs by sections of pharmaceutical industry</a>. The Telegraph India.</p> <p>Mar 29: <a href="https://eu.usatoday.com/story/news/health/2024/03/29/ozempic-wegovy-weight-loss-diabetes-drug-cost/73125135007" rel="external nofollow noopener" target="_blank">Weight-loss drugs cost $1,000 a month but less than $25 to make. Why do we pay so much?</a>. USA Today.</p> <p>Mar 29: <a href="https://qz.com/ozempic-price-backlash-study-sanders-1851374290" rel="external nofollow noopener" target="_blank">Ozempic costs just $5 to make, a study said. The backlash was swift.</a>. Quartz.</p> <p>Mar 29: <a href="https://www.statnews.com/2024/03/29/glp-1-insulin-generics-ozempic-drug-pricing" rel="external nofollow noopener" target="_blank">GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable.</a>. Stat News.</p> <p>Mar 29: <a href="https://www.bt.dk/sundhed/nyt-studie-populaer-medicin-koster-alt-alt-for-meget" rel="external nofollow noopener" target="_blank">Nyt studie: Populær medicin koster alt, alt for meget</a>. BT (Denmark).</p> <p>Mar 28: <a href="https://www.theguardian.com/global-development/2024/mar/28/drug-companies-diabetes-drugs-medicines-ozempic-trulicity" rel="external nofollow noopener" target="_blank">Study: ‘gamechanger’ diabetes drugs cost up to 400 times more than needed</a>. The Guardian.</p> <p>Mar 28: <a href="https://www.washingtonpost.com/politics/2024/03/28/state-sanctioned-hospital-monopoly-raises-concerns" rel="external nofollow noopener" target="_blank">Sanders presses Novo Nordisk over Ozempic, Wegovy prices</a>. The Washington Post.</p> <p>Mar 28: <a href="https://www.thehindubusinessline.com/companies/msf-costing-study-says-newer-diabetes-drugs-and-insulin-pens-priced-beyond-patient-reach/article67999181.ece" rel="external nofollow noopener" target="_blank">MSF’s costing study says newer diabetes drugs and insulin pens priced beyond patient reach</a>. The Hindu.</p> <p>Mar 28: <a href="https://www.businessinsider.com/bernie-sanders-ozempic-cheaper-novo-nordisk-2024-3" rel="external nofollow noopener" target="_blank">Bernie Sanders wants to make Ozempic cheaper</a>. Business Insider.</p> <p>Mar 28: <a href="https://endpts.com/bernie-sanders-implores-novo-to-cut-list-prices-of-ozempic-wegovy" rel="external nofollow noopener" target="_blank">Bernie Sanders implores Novo to cut list prices of Ozempic, Wegovy</a>. Endpoints News.</p> <p>Mar 28: <a href="https://nypost.com/2024/03/28/lifestyle/ozempic-which-costs-up-to-1300-can-be-made-for-5-study" rel="external nofollow noopener" target="_blank">Costly Ozempic jab, which costs up to $1,300, can be made for just $5, study claims</a>. New York Post.</p> <p>Mar 28: <a href="https://www.fiercepharma.com/pharma/high-markups-glp-1s-insulin-pens-present-barriers-access-lower-income-countries-report" rel="external nofollow noopener" target="_blank">High prices on GLP-1 meds, insulin pens raise barriers to access in lower-income countries: MSF</a>. Fierce Pharma.</p> <p>Mar 28: <a href="https://www.hln.be/medisch/amerikanen-betalen-er-bijna-1-000-euro-per-maand-voor-maar-afvalmiddel-ozempic-kan-voor-nog-geen-5-dollar-gemaakt-worden~a14c2868" rel="external nofollow noopener" target="_blank">Amerikanen betalen er bijna 1.000 euro per maand voor, maar afvalmiddel Ozempic kan “voor nog geen 5 dollar” gemaakt worden</a>. Het Laatste Nieuws (Belgium).</p> <p>Mar 28: <a href="https://theprint.in/health/ozempic-makers-could-be-raking-in-40000-profit-study-says-diabetes-drug-can-be-made-for-1-month" rel="external nofollow noopener" target="_blank">Ozempic makers could be raking in 40,000% profit — study says diabetes drug can be made for $1/month</a>. The Print.</p> <p>Mar 28: <a href="https://executivedigest.sapo.pt/noticias/medicamentos-modernos-para-a-diabetes-sao-vendidos-400-vezes-mais-caros-do-que-o-necessario-denuncia-estudo" rel="external nofollow noopener" target="_blank">Medicamentos modernos para a diabetes são vendidos 400 vezes mais caros do que o necessário, denuncia estudo</a>. Sapo (Portugal).</p> <p>Mar 27: <a href="https://timesofindia.indiatimes.com/business/india-business/huge-markup-on-prices-of-new-diabetes-medicines-and-insulin-pens/articleshow/108828024.cms" rel="external nofollow noopener" target="_blank">‘Huge markup on prices of new diabetes medicines and insulin pens’</a>. The Times of India.</p> <p>Mar 27: <a href="https://www.sanders.senate.gov/press-releases/news-sanders-statement-on-outrageous-cost-of-ozempic" rel="external nofollow noopener" target="_blank">Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices</a>. Office of Bernie Sanders.</p> <p>Mar 27: <a href="https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html" rel="external nofollow noopener" target="_blank">Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests</a>. CNBC.</p> <p>Mar 27: <a href="https://www.irishexaminer.com/business/companies/arid-41362483.html" rel="external nofollow noopener" target="_blank">Weight-loss drug ‘could be profitably made for as little as €4.40 a month’</a>. Irish Examiner.</p> <p>Mar 27: <a href="https://thehill.com/policy/healthcare/4560323-sanders-calls-for-novo-nordisk-slash-ozempic-wegovy-prices" rel="external nofollow noopener" target="_blank">Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices</a>. The Hill.</p> <p>Mar 27: <a href="https://www.bloomberg.com/news/articles/2024-03-27/ozempic-novo-s-1-000-diabetes-drug-can-be-made-for-less-than-5-a-month" rel="external nofollow noopener" target="_blank">Ozempic, Novo’s $1,000 Diabetes Shot, Can Be Made for Under $5 a Month</a>. Bloomberg.</p> <p>Mar 27: <a href="https://ottawacitizen.com/health/ozempic-the-1000-diabetes-drug-can-be-made-for-less-than-5-a-month-study" rel="external nofollow noopener" target="_blank">Ozempic, the $1,000 diabetes drug, can be made for less than $5 a month: study</a>. Ottawa Citizen.</p> <div style="text-align: center;"> <h5>2023</h5> </div> <p>Nov 29: <a href="https://healthjournalism.org/blog/2023/11/spotlight-the-harms-of-supply-shortages" rel="external nofollow noopener" target="_blank">Why it’s time to spotlight the harms of supply shortages</a>. Association of Health Care Journalists.</p> <p>Sept 15: <a href="https://www.fiercehealthcare.com/providers/health-subcommittee-members-odds-over-drafted-drug-shortage-legislation" rel="external nofollow noopener" target="_blank">Health subcommittee members at odds over drafted drug shortage legislation</a>. Fierce Healthcare.</p> <p>Sept 14: <a href="https://www.medpagetoday.com/publichealthpolicy/healthpolicy/106345" rel="external nofollow noopener" target="_blank">No ‘Silver Bullet’ for Generic Drug Shortage, House Members Told</a>. Medpage Today.</p> <p>Sept 14: <a href="https://rollcall.com/2023/09/14/partisan-divide-on-drug-shortages-unresolved-after-hearing" rel="external nofollow noopener" target="_blank">Partisan divide on drug shortages unresolved after hearing</a>. Roll Call News.</p> <p>May 2: <a href="https://www.ashecon.org/awards/introducing-the-2023-ashecon-award-winners" rel="external nofollow noopener" target="_blank">Introducing the 2023 ASHEcon Award Winners</a>. American Society of Health Economists.</p> <div style="text-align: center;"> <h5>2022</h5> </div> <p>July 22: <a href="https://www.poder360.com.br/coronavirus/lucro-das-maiores-farmaceuticas-cresce-41-na-pandemia" rel="external nofollow noopener" target="_blank">Lucro das maiores farmacêuticas cresce 41% na pandemia</a>. Poder360.</p> <p>July 22: <a href="https://www.poder360.com.br/coronavirus/farmaceuticas-podiam-cobrar-menos-diz-pesquisadora-de-harvard" rel="external nofollow noopener" target="_blank">Farmacêuticas podiam cobrar menos, diz pesquisadora de Harvard</a>. Poder360.</p> <p>July 12: <a href="https://www.forbes.com/sites/madhukarpai/2022/07/12/how-many-variants-and-deaths-are-we-willing-to-accept-before-we-protect-the-whole-world" rel="external nofollow noopener" target="_blank">How Many Variants And Deaths Are We Willing To Accept, Before We Protect The Whole World?</a>. Forbes.</p> <p>June 17: <a href="https://www.nytimes.com/2022/06/17/business/wto-covid-vaccine-patent.html" rel="external nofollow noopener" target="_blank">W.T.O. countries agree to a limited relaxing of patent protections on coronavirus vaccines</a>. New York Times.</p> <p>May 25: <a href="https://www.devex.com/news/behind-pfizer-s-new-not-for-profit-deal-on-patented-vaccines-and-drugs-103323" rel="external nofollow noopener" target="_blank">Behind Pfizer’s new not-for-profit deal on patented vaccines and drugs</a>. Devex.</p> <p>Apr 4: <a href="https://www.nature.com/articles/d41586-022-00919-5" rel="external nofollow noopener" target="_blank">African clinical trial denied access to key COVID drug Paxlovid</a>. Nature.</p> <p>Feb 28: <a href="https://www.corriere.it/dataroom-milena-gabanelli/paxlovid-molnupiravir-pillola-anti-covid-ricatto-case-farmaceutiche-sistemi-sanitari-tutti-guadagni/2fdb32ba-97d7-11ec-97aa-535db4de4386-va.shtml" rel="external nofollow noopener" target="_blank">Paxlovid e Molnupiravir, pillola anti-Covid: il ricatto delle case farmaceutiche ai sistemi sanitari</a>. Corriere della Sera.</p> <div style="text-align: center;"> <h5>2021</h5> </div> <p>Oct 4: <a href="https://www.statnews.com/pharmalot/2021/10/04/covid19-merck-molnupiravir-ridgeback-patents" rel="external nofollow noopener" target="_blank">Merck’s Covid-19 pill may be a game-changer, but questions are already being raised about cost</a>. STAT.</p> <p>Oct 19: <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-who-led-programme-aims-buy-antiviral-covid-19-pills-10-document-2021-10-19" rel="external nofollow noopener" target="_blank">WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document</a>. Reuters.</p> <p>Oct 17: <a href="https://www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.html" rel="external nofollow noopener" target="_blank">Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?</a>. New York Times.</p> <p>Oct 7: <a href="https://www.salon.com/2021/10/07/entirely-unsurprising-merck-slammed-for-4000-markup-of-taxpayer-funded-19_partner" rel="external nofollow noopener" target="_blank">Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug</a>. Salon.</p> <p>Oct 6: <a href="https://www.fiercepharma.com/pharma/amid-controversy-over-its-price-rush-to-secure-merck-and-ridgeback-s-covid-19-drug" rel="external nofollow noopener" target="_blank">Buyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is already controversial</a>. Fierce Pharma.</p> <p>Oct 6: <a href="https://www.independent.co.uk/news/world/americas/us-merck-covid-pill-cost-b1933100.html" rel="external nofollow noopener" target="_blank">Covid pill makers accused of selling drug to US at 40 times what it costs to make despite govt funding</a>. Independent.</p> <p>Oct 5: <a href="https://theintercept.com/2021/10/05/covid-pill-drug-pricing-merck-ridgeback" rel="external nofollow noopener" target="_blank">Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make</a>. The Intercept.</p> <p>Oct 4: <a href="https://www.fortuneindia.com/enterprise/why-mercks-new-covid-19-drug-banks-on-india-2/105949" rel="external nofollow noopener" target="_blank">Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill</a>. Fortune India.</p> <p>Oct 4: <a href="https://healthpolicy-watch.org/generic-companies-are-ready-to-make-mercks-covid-19-pill" rel="external nofollow noopener" target="_blank">Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill</a>. Health Policy Watch.</p> <div style="text-align: center;"> <h5>2020</h5> </div> <p>Sept 29: <a href="https://www.elespectador.com/salud/la-insulina-podria-ser-mas-barata-sin-que-las-farmaceuticas-pierdan-ganancias-segun-estudio-article-815051" rel="external nofollow noopener" target="_blank">La insulina podría ser más barata sin que las farmacéuticas pierdan ganancias, según estudio</a>. El Espectador.</p> <p>Aug 16: <a href="https://www.nbcnews.com/news/us-news/states-are-trying-cap-price-insulin-pharmaceutical-companies-are-pushing-n1236766" rel="external nofollow noopener" target="_blank">States are trying to cap the price of insulin. Pharmaceutical companies are pushing back</a>. NBC.</p> <div style="text-align: center;"> <h5>2019</h5> </div> <p>Nov 15: <a href="https://medium.com/@teamwarren/my-first-term-plan-for-reducing-health-care-costs-in-america-and-transitioning-to-medicare-for-all-8d45dd993872" rel="external nofollow noopener" target="_blank">Elizabeth Warren’s First Term Plan for Reducing Health Care Costs in America and Transitioning to Medicare for All</a>. Medium.</p> <p>Oct 8: <a href="https://www.newstatesman.com/politics/health/2019/10/why-would-government-make-its-own-drugs" rel="external nofollow noopener" target="_blank">Why would the government make its own drugs?</a>. New Statesman.</p> <p>June 25: <a href="https://www.wbur.org/news/2019/06/25/why-insulin-defies-the-normal-rules-of-economics-and-keeps-getting-more-expensive" rel="external nofollow noopener" target="_blank">Why Insulin Defies The Normal Rules Of Economics And Keeps Getting More Expensive</a>. WBUR.</p> <div style="text-align: center;"> <h5>2018</h5> </div> <p>Sept 25: <a href="https://www.statnews.com/pharmalot/2018/09/25/insulin-prices-profits-diabetes" rel="external nofollow noopener" target="_blank">Insulin prices could be much lower and drug makers would still make healthy profits</a>. STAT.</p> <div style="text-align: center;"> <h5>2017</h5> </div> <p>May 31: <a href="https://www.newscientist.com/article/mg23431281-100-big-pharma-makes-a-killing-off-deadly-diseases-what-can-stop-them" rel="external nofollow noopener" target="_blank">The drug rebellion fighting big pharma to save the NHS millions</a>. New Scientist.</p> <p>May 16: <a href="https://www.pmlive.com/pharma_news/eu_starts_investigation_of_aspens_cancer_drug_pricing_1192899" rel="external nofollow noopener" target="_blank">EU starts investigation of Aspen’s cancer drug pricing</a>. PmLiVE.</p> <p>Jan 30: <a href="https://www.statnews.com/pharmalot/2017/01/30/cancer-generics-drug-prices" rel="external nofollow noopener" target="_blank">Price hikes for some generic cancer drugs in the UK have skyrocketed</a>. STAT.</p> <p>Jan 29: <a href="https://www.bbc.com/news/health-38769625" rel="external nofollow noopener" target="_blank">Cancer drugs price rise ‘costing NHS millions’</a>. BBC.</p> <p>Jan 28: <a href="https://www.theguardian.com/society/2017/jan/28/nhs-drug-firms-cancer-patients-at-risk-prices-inflated" rel="external nofollow noopener" target="_blank">Drugs firms are accused of putting cancer patients at risk over price hikes</a>. The Guardian.</p> </article> </div> </div> <footer class="sticky-bottom mt-5" role="contentinfo"> <div class="container"> © Copyright 2025 Melissa Barber. This is my personal academic website. All research, analysis, and commentary published here represent my independent academic work and should not be construed as reflecting the views of any current or former employer or institutional partner. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?2781658a0a2b13ed609542042a859126"></script> <script defer src="/assets/js/common.js?e0514a05c5c95ac1a93a8dfd5249b92e"></script> <script defer src="/assets/js/copy_code.js?c8a01c11a92744d44b093fc3bda915df" type="text/javascript"></script> <script defer src="/assets/js/jupyter_new_tab.js?d9f17b6adc2311cbabd747f4538bb15f"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/tex-mml-chtml.js" integrity="sha256-MASABpB4tYktI2Oitl4t+78w/lyA+D7b/s9GEP0JOGI=" crossorigin="anonymous"></script> <script src="/assets/js/mathjax-setup.js?a5bb4e6a542c546dd929b24b8b236dfd"></script> <script defer src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" crossorigin="anonymous"></script> <script defer src="/assets/js/progress-bar.js?2f30e0e6801ea8f5036fa66e1ab0a71a" type="text/javascript"></script> <script src="/assets/js/vanilla-back-to-top.min.js?f40d453793ff4f64e238e420181a1d17"></script> <script>
    addBackToTop();
  </script> <script type="module" src="/assets/js/search/ninja-keys.min.js?a3446f084dcaecc5f75aa1757d087dcf"></script> <ninja-keys hidebreadcrumbs noautoloadmdicons placeholder="Type to start searching"></ninja-keys> <script src="/assets/js/search-setup.js?6c304f7b1992d4b60f7a07956e52f04a"></script> <script src="/assets/js/search-data.js"></script> <script src="/assets/js/shortcut-key.js?6f508d74becd347268a7f822bca7309d"></script> </body> </html>